Literature DB >> 1727834

Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men.

J D Veldhuis1, G Lizarralde, A Iranmanesh.   

Abstract

We investigated the effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in healthy men. Subjects (n = 5) underwent blood sampling at 10-min intervals for 6 h before and on days 2, 5, and 8 of glucocorticoid treatment, and for 24 h (n = 6) to examine pulsatile LH and GH release before and during dexamethasone administration (1.5 mg orally twice daily for 1 week). In the time-course study, we found significant decreases on day 8 in serum concentrations of estradiol (from 144 +/- 18 to 99 +/- 18 pmol/L), free testosterone (from 105 +/- 10 to 87 +/- 10 pmol/L), and dehydroepiandrosterone sulfate (from 6.0 +/- 1.6 to 1.7 +/- 0.3 mumol/L; P less than 0.05). Mean serum LH concentrations did not change (baseline, 5.3 +/- 1.2 IU/L; glucocorticoid, 4.2 +/- 0.61 IU/L). The mean plasma somatomedin-C concentration rose from 0.74 +/- 0.08 to 2.0 +/- 0.35 U/mL (P less than 0.05), and the mean serum GH concentration increased from 1.2 +/- 0.90 micrograms/L (basal) to 4.2 +/- 1.5 micrograms/L (day 8 of dexamethasone; P less than 0.01). Deconvolution analysis of 24-h serum GH and LH concentration profiles revealed that the half-life of endogenous GH and the duration and amplitude (maximal rate of secretion) of computer-resolved GH secretory bursts were not influenced significantly by dexamethasone. The mass of GH secreted per burst rose 1.6-fold. Glucocorticoid treatment also increased detectable GH secretory burst frequency from 12 +/- 1.6 to 18 +/- 1.6 episodes/24 h, decreased the GH interburst interval from 127 +/- 23 to 79 +/- 5 min, and increased the daily GH secretion rate from 41 +/- 11 to 101 +/- 11 micrograms/L.day. These effects on the somatotropic axis were specific, since the half-life of LH; LH secretory burst frequency, amplitude, mass, and duration; and the total daily LH production rate (and LH secretion in response to exogenous GnRH) were not altered by dexamethasone administration. We conclude that short term moderate glucocorticoid excess augments pulsatile GH secretion without influencing the episodic release of LH in normal men.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727834     DOI: 10.1210/jcem.74.1.1727834

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Age and testosterone feedback jointly control the dose-dependent actions of gonadotropin-releasing hormone in healthy men.

Authors:  Johannes D Veldhuis; Ali Iranmanesh; Thomas Mulligan
Journal:  J Clin Endocrinol Metab       Date:  2004-10-19       Impact factor: 5.958

2.  Dexamethasone does not increase IGF-I and IGFBP-3 levels in man in the absence of endogenous GH.

Authors:  F E Finamor; A M Lengyel
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

3.  Testosterone's short-term positive effect on luteinizing-hormone secretory-burst mass and its negative effect on secretory-burst frequency are attenuated in middle-aged men.

Authors:  Peter Y Liu; Paul Y Takahashi; Pamela D Roebuck; Joy N Bailey; Daniel M Keenan; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

4.  Age in men does not determine gonadotropin-releasing hormone's dose-dependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp.

Authors:  Ali Iranmanesh; Thomas Mulligan; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2010-03-31       Impact factor: 5.958

5.  IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man.

Authors:  M H Borges; A C Pinto; F B DiNinno; C Camacho-Hübner; A Grossman; C E Kater; A M Lengyel
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

6.  The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-1.

Authors:  M F Prummel; W M Wiersinga; H Oosting; E Endert
Journal:  J Endocrinol Invest       Date:  1996-10       Impact factor: 4.256

7.  Serum testosterone levels after cardiac transplantation.

Authors:  Jessica Fleischer; Donald J McMahon; Wylie Hembree; Vicki Addesso; Christopher Longcope; Elizabeth Shane
Journal:  Transplantation       Date:  2008-03-27       Impact factor: 4.939

8.  Dynamic Interactions Between LH and Testosterone in Healthy Community-Dwelling Men: Impact of Age and Body Composition.

Authors:  Ferdinand Roelfsema; Peter Y Liu; Paul Y Takahashi; Rebecca J Yang; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

9.  Aromatase activity and bone loss in men.

Authors:  Daniela Merlotti; Luigi Gennari; Konstantinos Stolakis; Ranuccio Nuti
Journal:  J Osteoporos       Date:  2011-06-24

Review 10.  Neural immune pathways and their connection to inflammatory diseases.

Authors:  Farideh Eskandari; Jeanette I Webster; Esther M Sternberg
Journal:  Arthritis Res Ther       Date:  2003-09-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.